Huma Therapeutics
Huma is a global healthcare AI company on a mission to accelerate the adoption of digital solutions in care and research. The company is renowned for its role in major national healthcare projects worldwide as well as collaborating with most large pharma companies
Caresyntax
Caresyntax offers AI-powered software, devices, and clinical services designed to enhance surgical outcomes. With a significant global presence in operating rooms, their technology has been utilized in millions of surgeries and boasts a substantial user base of surgical professionals.
NETTWORK HOLDINGS
Nettwork Holdings is a distribution focused company that supports commercialization efforts across the healthcare ecosystem.
Ansella Therapeutics
Ansella Therapeutics is specialty pharmaceutical company that leverages biomimetic sciences to develop novel therapeutics that improve healthcare outcomes. The company’s initial focus is on women’s health, specifically in the development of novel vaginal formulations.
Avive Solutions
Avive is a MedTech company that has developed a next-generation automated external defibrillator (AED) and software solutions that revolutionizes the current sudden cardiac arrest (SCA) response.
Endeavor Biomedicines
Endeavor’s ENV-101 is a second-generation Hedgehog inhibitor with a highly favorable efficacy and side-effect profile compared to the molecules currently in the market. ENV-101 inhibits target pathway by ~90% at all tested doses.
VIVANCE Technologies
VIVANCE Technologies is a clinical-stage, medical device company that has developed a disruptive peritoneal dialysis (PD) device based on revolutionary new filtration technology developed in-house.
Sanoculis
Sanoculis has developed MIMS (Minimally Invasive Micro Sclerostomy), for treating glaucoma – the only minimally invasive procedure that delivers excellent reductions in intra-ocular pressure but leaves no implant in the eye. A MIMS procedure can be performed in about 5 minutes and requires significantly less operator skill, this means lower skilled operators can treat a […]
Sonrai Analytics
Cutting-edge technology to enable discovery within precision healthcare. Sonrai’s ability to manage and analyze integrated data uniquely positions the company to support biotech and pharma in the search for new drug development.
Enquyst Technologies
Enquyst Technologies is developing the next-generation biopharmaceutical manufacturing platform which aims to redesign the downstream bioprocess equipment to bring unprecedented advantages in cost, time, footprint, and speed to market at commercial scale.
